Welcome to our dedicated page for Phreesia SEC filings (Ticker: PHR), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Phreesia filings document the company’s operating results, material agreements, capital structure and governance as a public healthcare technology company. Recent Form 8-K disclosures include quarterly financial results, stakeholder letters and earnings-call materials, along with material definitive agreements connected to credit facilities, acquisition financing and receivables arrangements.
The filing record also documents the completed AccessOne acquisition, the use and refinancing of related debt, and subsidiary arrangements involving AccessOne Funding and AccessOne MedCard. Governance disclosures include board composition changes, director compensation matters and shareholder-voting subjects, while capital-structure disclosures cover secured revolving credit, bridge-loan obligations and receivables purchase agreements.
Phreesia, Inc. reported a profitable quarter for the three months ended April 30, 2026, with total revenues of $130,935 thousand and net income of $2,963 thousand, compared with a net loss a year earlier. Revenue came from subscription and related services, payment solutions, and network solutions.
Operating income was $6,749 thousand as expense growth lagged revenue growth. Cash, cash equivalents and restricted cash were $76,397 thousand, and net cash provided by operating activities was $23,922 thousand, showing stronger cash generation.
The company refinanced its short-term bridge loan with a new five-year $275,000 senior secured revolving credit facility, of which $84,240 thousand was outstanding as of April 30, 2026. Management believes current liquidity and cash flows are sufficient for at least the next 12 months.
Phreesia reported a profitable start to fiscal 2027, with solid growth and stronger cash generation. Fiscal first-quarter revenue reached $130.9 million, up 13% year-over-year, led by 40% growth in payment solutions and 15% growth in network solutions, while subscription and related services declined 3%.
The company served an average of 4,708 healthcare services clients, up 7%, and total revenue per client rose 6% to $27,811. Net income was $3.0 million, compared with a $3.9 million loss a year earlier, and Adjusted EBITDA increased to $30.5 million from $20.8 million. Operating cash flow improved to $23.9 million and free cash flow to $16.4 million.
Phreesia refinanced its bridge loan with a new $275 million senior secured revolving credit facility and ended the quarter with $76.4 million in cash, cash equivalents and restricted cash and $84.2 million outstanding under the new facility. It also expanded AccessOne’s securitization program with PNC Bank from $200 million to $300 million and extended it to 2029.
The company implemented a restructuring of its Engineering and Product organizations, eliminating roughly 200 internal and contractor roles to embed AI and improve efficiency, with expected savings already reflected in guidance. For fiscal 2027, Phreesia is maintaining its outlook for revenue of $510–$520 million and Adjusted EBITDA of $125–$135 million, assuming about $37 million of revenue from AccessOne, mid-single-digit percentage growth in healthcare services clients and low-single-digit percentage growth in revenue per client. Management notes that some network solutions clients are committing lower spend in the second half of the year, introducing more variability into that revenue stream, while demand in other areas is tracking prior expectations.
Phreesia, Inc. Principal Accounting Officer Yvonne Hui reported small share transactions on Common Stock. She sold 431 shares at $8.85 per share in an open-market transaction that was carried out under a pre-arranged Rule 10b5-1 trading plan adopted on January 15, 2026.
Separately, 325 shares were withheld at $8.77 per share to cover tax obligations tied to the settlement of restricted stock units. The filing notes this tax withholding does not represent a discretionary sale by Hui, indicating the main market-directed activity is the modest planned sale.
PHR filed a Rule 144 notice reporting restricted-stock vesting and sales of Common Stock. The filing lists a restricted stock vesting event on 05/15/2026 and two reported dispositions by Yvonne Hui of 10,063 shares on 04/16/2026 and 1,327 shares on 04/17/2026.
Additional line items show a quantity 431 tied to securities information and an entry dated 05/18/2026 on the NYSE. The filing appears administrative, reporting compensation-related vesting and subsequent sales.
Phreesia, Inc. is asking stockholders to vote at its virtual 2026 annual meeting on June 24, 2026. The ballot includes electing two Class I directors, Chaim Indig and Jon Kessler, ratifying KPMG LLP as independent auditor for the fiscal year ending January 31, 2027, and an advisory vote on executive compensation.
The board will shrink from nine to seven directors as two current directors retire, with independent director Ramin Sayar becoming chair after the meeting. Phreesia highlights a highly independent and diverse board, fully independent key committees, stock ownership guidelines, and NYSE‑compliant clawback and risk oversight practices.
Phreesia, Inc. has launched a restructuring plan aimed at reducing operating expenses and aligning its cost structure with current business priorities. The plan includes eliminating approximately 220 positions, with around half coming from contractor roles.
The company does not expect restructuring costs to be material and anticipates most will occur during fiscal year 2027. Management expects the plan to generate meaningful annualized run-rate expense savings, which were already incorporated into its Adjusted EBITDA outlook for fiscal year 2027 shared on March 30, 2026. These expectations depend on various assumptions, and actual results could differ.
CAHILL EDWARD L reported acquisition or exercise transactions in this Form 4 filing.
Phreesia, Inc. director Edward L. Cahill received a grant of 1,085 shares of Common Stock valued at $9.21 per share. This award reflects deferred stock units taken instead of an annual cash retainer under Phreesia’s Non-Employee Director Deferred Compensation Program.
Following this compensation grant, Cahill directly holds 65,613 shares of Phreesia common stock. The footnote explains that the underlying common stock will be delivered either after he leaves the board and has a qualifying separation from service, or five years after the grant date.
Goldstein Lainie reported acquisition or exercise transactions in this Form 4 filing.
Phreesia director Lainie Goldstein reported a routine equity award. Goldstein received 1,085 deferred stock units tied to Phreesia common stock at a reference price of $9.21 per share, in lieu of a quarterly cash retainer. After this grant, her directly held common stock position is reported at 51,195 shares.
Phreesia director Gillian Munson received an award of 1,085 deferred stock units valued at $9.21 per unit instead of an annual cash retainer. These units convert into common shares after she leaves the board or five years from grant, bringing her direct holdings to 46,814 shares.